Related Experiment Videos
Combined treatment of atrial fibrillation with propranolol and quinidine
Cardiology
|January 1, 1970
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Corrigendum to "Cost-effectiveness of first-line osimertinib informed by electronic medical records via text-mining: a real-world Italian case study of EGFR-mutated advanced NSCLC patients": [ESMO Real World Data and Digital Oncology Volume 10, December 2025, 100198].
ESMO real world data and digital oncology·2026
Data analytics for real-world data integration in TKI-treated NSCLC patients using electronic health records.
ESMO real world data and digital oncology·2026
Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671).
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Aldosterone synthase inhibitors may alter how primary care treats hypertension.
American journal of hypertension·2026
The hypertension specialist's perspective: aldosterone synthase inhibitors to fill the gap in difficult-to-control and resistant hypertension.
American journal of hypertension·2026
From bench to formulary: a pharmacological appraisal of aldosterone synthase inhibitors for uncontrolled and resistant hypertension.
American journal of hypertension·2026